Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
The Importance of Cardiac Output Monitoring in Paediatric Management Dr Joe Brierley Paediatric and Neonatal Intensive Care Units Great Ormond St Hospital London, UK Cardiac function n Systolic AND diastolic function • Systolic function • Diastolic function n n rate and degree of ventricular relaxation both active and passive components Cardiac Function-Systolic n Systolic cardiac function • interaction of four interdependent factors: Heart rate n Preload n Contractility n Afterload n n Heart rate measurable Preload - invasive pressure - CVP/PA wedge Contractility and afterload -difficult (FS/conductance/SVR) n ICU cardiac function - bedside cardiac output n n Cardiac function Adequacy of cardiac output and oxygen delivery n Global assessment n n n MVO2 lactate Regional assessment n n n n capillary refill core-peripheral temperature gap splanchnic oxygen delivery-gastric tonometry secondary organ effects • renal/hepatic/neurological failure Assessing circulatory disturbances n Clinical estimate of cardiac output poor (1) n ‘Clinicians substitute BP for flow’ • no correlation between flow + pressure n Plethora of methods to estimate CO • each potential for measurement errors • requirement for technical expertise may limit utility • degree of invasiveness required ⇒ incremental risk to pt 1) Tibby S et al. Clinicians’ abilities to estimate cardiac index in ventilated children and infants. Arch Dis Child 1997;77:516–18 Caveat n Flow without Hb + art’ sats - ?misleading n Cellular viability depends • O2 delivery (CO X arterial oxygen content) • O2 extraction n As well as CO Cardiac output n Volume of blood ejected by heart per minute n NB Interplay - HR preload contractility + afterload n Manifestation of cardiac function measurable at bedside n In children indexed to BSA-cardiac index • same “normal” value n -3.5–5.5 l/min/m2 regardless age/size Why Measure CO in ICU n n n n n CVS one of commonest organ failures in PICU (Wilkinson) Other organ failure/support effects myocardial function - eg ventilation/CVVH Low flow state • high mortality in certain diseases (Mercier JC et al) Flow poorly estimated clinically (Tibby et al) • Hence titrate treatment against BP! Adequate organ perfusion pressure vital • BUT BP affected by CO and SVR •Wilkinson et al. Outcome of pediatric patients with MOSF. Crit Care Med 1986;14:271–4 •Mercier JC et al Hemodynamic patterns of meningococcal shock in children. CCM 1988;16:27 •Tibby et al Clinicians’ abilities to estimate CI in ventilated children and infants. Arch Dis Child 1997;77:516–18 When to measure CO n n Not all children in ICU Risk v benefit Risk ? children outside ICU Patient selection Method used n Benefit Understand haemodynamics Thompson A. Pulmonary artery catheterization in children. New horiz 1997;5:244–50 n • Shock states • Congenital and acquired heart disease • Multiple organ failure • Cardiopulmonary interactions during mechanical ventilation Also • Research • Monitoring effects of drugs eg anaesthetic agents • ? Role in early goal therapy prior to ICU Accuracy vital as ultimate aim to change therapy When to measure CO in ICU n Evidenced based medicine • CO not (yet) convincingly shown to improve outcome n But same for many monitoring procedures • • • • invasive arterial pressure CVP measurement blood gas analysis pulse oximetry • NB CVO2 Anyone like to NOT know her cardiac output? Flow more important than pressure! Goal Therapy-Adjustments in:Modality Gold standard ICU manipulation Pre-load LVEDP fluids/CVP Systolic function Contractility (conductance) Inotropes Diastolic function Relaxation (ino-)Dilators Afterload SVR Ventriculo-arterial coupling -Ees/Ea Aim to balance O2 delivery with O2 demand n End points n n n n Normalized MVO2 Arterial lactate Base deficit pH Goal Therapy n MVO2 • Good surrogate for cardiac index (assuming constant n n -O2 consumption, Hb concentration, arterial O2 saturation) Gattinoni et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995;333:1025-32 CVO2 • Reasonable surrogate for MVO2 n Reinhart et al. Comparison of CV to MV O2 sats during changes in O2 supply/demand.Chest 1989;95:1216-21 Paediatric Sepsis n ? Manipulation other variables equally successful n n Eg Cardiac output ? Any of this valid in children Role of early fluid resuscitation in pediatric septic shock. Carcillo JA, Davis AL, Zaritsky A. JAMA 1991 4;266(9):1242-5 40 mL/kg in the first hour following ED presentation associated with: improved survival Early Reversal of PediatricPediatric-Neonatal Septic Shock by Community Physicians Is Associated With Improved Outcome Yong Y. Han, Joseph A. Carcillo, Carcillo Michelle A. Dragotta, Debra M. Bills, R. Scott Watson, Mark E. Westerman, and Richard A. Orr. Pediatrics, Oct 2003; 112: 793 - 799. Each extra hour of shock: 2.3x risk of death Ideal characteristics -CO device • Non-invasive • Applicable to many patients • Applicable over a wide range of flow • Accurate (cf other techniques) • Reproducible • Easy to use • Rapid data acquisition • Cost effective How to measure cardiac output n Invasive • Dilution techniques • Dye dilution • Pulmonary artery thermodilution • Transpulmonary thermodilution • Lithium dilution • Direct Fick n Non-Invasive • Non-invasive Fick using CO2 • Bioimpedance • Echocardiography • Trans-oesophageal doppler • Pulse contour analysis • Supra-sternal/USCOM PA catheter Swan HJ et al. Catheterization of heart in man with flow-directed, balloon-tipped catheter. N Engl J Med 283:477, 1970 n Traditional ICU estimation CO • cold dextrose ⇒ Rt atrium ⇒ PA temp’ change (thermistor) • CO calculated- temperature time curve • Disadvantages n technical limitations n catheter-related problems n Usually on ICU n skilled operator (1,2) n n (1) Iberti T et al. A multicenter study of physicians’ knowledge of PA catheter. JAMA. 1990;264:2928–32 (2) Gnaegi A, Feihl F, Perret C. Intensive care physicians’ insufficient knowledge of Rt-heart catheterization at bedside: time to act? CCM 1997;25:213–20 Measuring Cardiac Output Invasive Adolph Fick 1870 Fick equation -‘gold standard’ CO calculated → n Art-Venous-O2 content difference & O2 consumption • O2 consumption (spirometry) and O2 content (ABG) • MVO2 needs PA catheter • • technical skill -unfeasible as routine several devices use variants Measuring Cardiac Output- Invasive Fick principle with CO2 n Total Re-breathing Cardiac Output CO2 not eliminated-exhaled CO2 approaches MVCO2 Et CO2 - non-invasive estimate of PaCO2 Pulse contour analysis "Upon the amount of blood that is thrown out by the heart during systole then, does the magnitude of the pulse-pressure in the aorta depend“ 1904 Erlanger and Hooker • Relation CO and arterial pulse contour Pulse contour analysis PiCCO • • • • Area under systolic portion of pulse pressure waveform Calibration -transpulmonary thermodilution 4-Fr arterial probe -so older children Now 1.3 Fr probe PICCO-parameters obtained Transpulmonary Thermodilution n n n n n n n Transpulmonary CO Intrathoracic blood volume Global end-diastolic volume Extravascular lung water Pulmonary vascular permeability index Cardiac Function Index Global Ejection Fraction Continuous Pulse Contour Analysis n n n n n n n n Continuous Pulse Contour CO ABP Heart Rate Stroke Volume Stroke volume variation SVR Index of left ventricular contractility Pulse pressure variation Pulse contour analysis PulseCO [LiDCO, UK) Frequency analysis n n n n n n aortic impedance aorta-radial transfer function aortic flow radial pressure Need radial arterial line + calibration -lithium dilution infants and children Partial Rebreathing Cardiac Output Indirect Fick (Non Invasive -NICO) n VCO2 = CO x (CvCO2 — CaCO2) But CvCO2 ‘invasive’ n Assuming CvCO2 + CO constant 3 mins • VCO2N-VCO2R = CO x (CaCO2R-CaCO2N) → CO = (VCO2N—VCO2R)/(CaCO2R-CaCO2N) *Pulmonary shunt correction computed Cardiac Output Non-invasively -Doppler n Suprasternal and pulmonary Transgastric Trans-oesophageal n Oesophageal Doppler CO n n • described 1971, refined 1989 • validated in children n Use of trans-oesophageal Doppler ultrasonography in ventilated pediatric patients: Derivation of cardiac output. Tibby et al. Critical Care Medicine: 28(6) June 2000 pp 2045-2050 Technical basis for technique n Concept flow in cylinder = CSA of cylinder X velocity of fluid in cylinder n For aortic blood flow • movement of blood pulsatile and velocity changes with time ⇒Velocity characterized by area under velocitytime curve between two points in time Oesophageal Doppler In ICU Ideal characteristics continuous CO device • Non-invasive • Automatic and non-operator dependent • Accurate (compared to other techniques) • Continuous, real time data display • Easy to use • No calibration required • Cost effective USCOM-suprasternal aortic + pulmonary USCOM CARDIAC OUTPUT MONITORING ON RETRIEVAL JJ Brierley and MJ Peters. Paediatric Intensive Care unit. Great Ormond St Hospital, London, UK 0.3 0.2 0.1 Intermeasurement Variability in CI l/min/m2 0 0 1 2 3 4 5 6 7 Mean CI -0.1 -0.2 -0.3 -0.4 0.3 0.2 0.1 Intermeasurement 0 Variability in CI 0 l/min/m2 -0.1 -0.2 -0.3 -0.4 2 4 6 8 10 12 14 Age (ye ar s ) 12 retrievals Range of ages 6 months-12 years Differing diagnosis Results: 36 cardiac outputs performed 4 successful readings per case Median time to obtain data 7 minutes Cardiac index-low variability -across range of ages and mean cardiac index When to measure CO with USCOM n EARLY goal therapy AND RETRIEVAL • (-NB CvCO2 invasive in coagulopathic septic infant) n ICU • USCOM n n n PORTABLE ROBUST Accurate in adults, paed study being done The Future Benefits of cardiac output Early warning monitoring Rational fluid and drug administration Decreased procedural complications e.g. bolus injections/vascular access n n n Use for CVS physiology in well children Smart resuscitation n n • n ie Early Goal directed therapy Prospect of outcome modification ? Questions